LLY241227C890000
- 0.22
- 0.000.00%
Eli Lilly and Co Newsroom
The USA FDA has revoked the emergency use authorization for four COVID-19 antibody drugs.
On December 24, Gelonghui reported that the USA Food and Drug Administration (FDA) has revoked the emergency use authorization for four COVID-19 antibody drugs, including Eli Lilly and Co's bebtelovimab, AstraZeneca's Evusheld, GlaxoSmithKline's sotrovimab, and Regeneron's REGEN-COV. The FDA stated in a letter earlier this month that the shelf life of these drugs has expired, and due to the spread of non-susceptible variants, they have not been authorized for patient use for more than a year. According to the FDA, the four companies mentioned above do not intend to continue providing the relevant products in the USA and will notify customers and suppliers.
With EPS Growth And More, Eli Lilly (NYSE:LLY) Makes An Interesting Case
Eli Lilly's Anti-Obesity Drug Mounjaro to Be Supported by UK Public Health System for Some Patients
U.S. stocks closed higher | The three major Indexes collectively rose, with the Nasdaq increasing by nearly 1%; chip stocks surged, with Broadcom and Taiwan Semiconductor rising over 5%, and NVIDIA increasing nearly 4%.
① The Nasdaq China Golden Dragon Index rose by 0.91%; ② The PHLX Semiconductor Index rose by over 3%; ③ MicroStrategy purchased 5,262 Bitcoins; ④ The suspect in the UnitedHealth executive's murder case pleaded not guilty.
Sector Update: Health Care Stocks Advance Late Afternoon
Ely Lilly Shares Are Trading Higher After the FDA Approved the Company's Zepbound, a Weight Loss Drug Designed to Treat Moderate-to-severe Obstructive Sleep Apnea in Adults With Obesity.
Eli Lilly Stock Is Rising Monday: What's Going On?
These Stocks Are Moving the Most Today: Honda, Qualcomm, Broadcom, Lilly, ResMed, Tesla, Walmart, Rumble, and More -- Barrons.com
Lilly, Amgen Sue HHS Over Certification of Drug Discount Program Recipients
Express News | Lilly: Will Continue to Pursue Appropriate Legal Avenues Against Those Importing Illicit Tirzepatide Knockoffs - Website
Express News | Lilly: Judge Overseeing Itc Case Determined U.S. Customs and Border Protection Should Prevent Illicit Import of Knock-off Tirzepatide Products
Express News | US FDA: Revoked Emergency Use Authorization for Lilly's Bebtelovimab as of Dec 13 - Website
ResMed, Inspire Medical Fall After Lilly's Zepbound Gains Sleep Apnea Indication
Sector Update: Health Care Stocks Fall Premarket Monday
Does Eli Lilly (NYSE:LLY) Deserve A Spot On Your Watchlist?
Express News | Resmed Shares Down 5.2% Premarket After U.S. FDA Approves Lilly's Weight-Loss Drug for Sleep Apnea
Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark
Lilly's Zepbound Receives FDA Approval for Sleep Apnea
Express News | RPT-Buzz-US Stocks Weekly: Snow Squall
These Stocks Are Moving the Most Today: Honda, Nissan, Qualcomm, Eli Lilly, Tesla, Rumble, and More -- Barrons.com